CN106619817A - Medicine for treating inflammation of nasal cavity, and preparation method of medicine - Google Patents
Medicine for treating inflammation of nasal cavity, and preparation method of medicine Download PDFInfo
- Publication number
- CN106619817A CN106619817A CN201710068880.XA CN201710068880A CN106619817A CN 106619817 A CN106619817 A CN 106619817A CN 201710068880 A CN201710068880 A CN 201710068880A CN 106619817 A CN106619817 A CN 106619817A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- herba
- nasal cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating the inflammation of the nasal cavity. The medicine is prepared from the following raw materials in parts by weight: 3-5 parts of liquorice root, 3-5 parts of honeysuckle flower, 3-5 parts of tetrapanax papyriferus, 3-5 parts of herba menthae, 3-5 parts of rhizoma chuanxiong, 5-10 parts of flos magnoliae, 5-10 parts of semen cassiae, 5-10 parts of radix notoginseng powder, 5-10 parts of radix saposhnikoviae, 5-10 parts of herba ephedrae, 5-10 parts of folium artemisiae argyi, 5 parts of squama manitis, 10-15 parts of herba centipedae, 10-15 parts of herba asari, 10-15 parts of radix sophorae flavescentis, 10-15 parts of fructus gleditsiae abnormalis, 10-15 parts of radix astragali seu hedysari, 10-15 parts of radix angelicae dahuricae and 20 parts of fructus xanthii. The medicine disclosed by the invention has the effect of treating the inflammation of the nasal cavity, and is remarkable in curative effect; relapse is uneasy to occur after healing; the medicine is capable of fundamentally curing the years of inflammation of the nasal cavity and is high in cure rate; furthermore, when in use, the medicine is directly applied to the nasal cavity, does not enter blood circulation, does not hurt liver or kidney, and does not affect work and study in medication period.
Description
Technical field
The invention belongs to the technical field of Chinese medicine, especially a kind of to treat medicine of nasal cavity inflammation and preparation method thereof.
Background technology
Rhinitis is the inflammation of the bronchia mucosal that virus, antibacterial, allergen, various physical and chemical factors and some systemic diseases cause
Disease, is a kind of commonly encountered diseases, frequently-occurring disease, and produces the most based on middle juvenile crowd of nasal cavity inflammation, accounts for the 30%- of total population
50%, headache and dizzy can also affect normal work and the life of patient caused by sinusitis, and be easy to cause other respiratory tracts
Disease, such as:Pharyngitis, pharyngolaryngitis, otitis media, while being also possible to that nasopharyngeal carcinoma can be caused.
The content of the invention
To solve an existing difficult problem above, the invention discloses a kind of treat medicine of nasal cavity inflammation and preparation method thereof.
A kind of medicine for treating nasal cavity inflammation, its raw material comprising following weight portion:Radix Glycyrrhizae 3-5 parts, Flos Lonicerae 3-5 parts,
Medulla Tetrapanacis 3-5 parts, Herba Menthae 3-5 parts, Rhizoma Chuanxiong 3-5 parts, Flos Magnoliae 5-10 parts, Semen Cassiae 5-10 parts, Radix Notoginseng powder 5-10 parts, Radix Saposhnikoviae 5-10
Part, Herba Ephedrae 5-10 parts, Folium Artemisiae Argyi 5-10 parts, 5 parts of Squama Maniss, sandwort 10-15 parts, Herba Asari 10-15 parts, Radix Sophorae Flavescentiss 10-15 parts, Fructus Gleditsia
10-15 parts, Radix Astragali 10-15 parts, Radix Angelicae Dahuricae 10-15 parts, 20 parts of Fructus Xanthii.
A kind of manufacture method of the medicine for treating nasal cavity inflammation, the manufacture method is comprised the following steps:
A, by Radix Glycyrrhizae, Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Squama Maniss,
Sandwort, Herba Asari, Radix Sophorae Flavescentiss, Fructus Gleditsia, the Radix Astragali, the Radix Angelicae Dahuricae, Fructus Xanthii immersion boiling water middling speed are quickly picked up after scalding, then scald speed
Raw material afterwards is dried;
B, by the raw material after drying respectively with steel mill smash, then sieved;
C, Radix Glycyrrhizae, Fructus Gleditsia, the Radix Astragali are put in pot and are stir-fried, till parching to brown, be subsequently poured into standby in vessel;
D, pour toward in pot cotton oil into, slow fire is boiled;
E, by Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Squama Maniss, goose not
Food, Herba Asari, Radix Sophorae Flavescentiss, the Radix Angelicae Dahuricae and Fructus Xanthii are poured in the pot for be equipped with cotton oil and are boiled, and boil 30 minutes;
F, the Radix Glycyrrhizae by after step c, Fructus Gleditsia, the Radix Astragali are added in pot, are stirred;
Proper amount of gypsum is added in g, past pot to carry out carrying hard;
H, by carry it is hard after raw material dry;
I, the raw material for drying is put in microwave oven and is toasted, then ground raw material pulverizing with steel, obtain final product medicine of the present invention;
J, by obtained medicine in step i be put in plastic casing seal.
Further, the cotton oil weight poured in step d and Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, three
The ratio of the weight summation of seven powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Squama Maniss, sandwort, Herba Asari, Radix Sophorae Flavescentiss, the Radix Angelicae Dahuricae and Fructus Xanthii is 1:
1。
Beneficial effect:Medicine disclosed by the invention has functions that to treat nasal cavity inflammation, evident in efficacy, not multiple after healing
Send out, nasal cavity inflammation for many years can be effected a radical cure, cure rate is high, and the present invention is direct enterprising nasal cavity when using, and will not be entered
Blood circulation, impairing the liver kidney, does not interfere with working and learning during medication.
Specific embodiment
In conjunction with the embodiments, the present invention is described in further details.
A kind of medicine for treating nasal cavity inflammation, its raw material comprising following weight portion:Radix Glycyrrhizae 3-5 parts, Flos Lonicerae 3-5 parts,
Medulla Tetrapanacis 3-5 parts, Herba Menthae 3-5 parts, Rhizoma Chuanxiong 3-5 parts, Flos Magnoliae 5-10 parts, Semen Cassiae 5-10 parts, Radix Notoginseng powder 5-10 parts, Radix Saposhnikoviae 5-10
Part, Herba Ephedrae 5-10 parts, Folium Artemisiae Argyi 5-10 parts, 5 parts of Squama Maniss, sandwort 10-15 parts, Herba Asari 10-15 parts, Radix Sophorae Flavescentiss 10-15 parts, Fructus Gleditsia
10-15 parts, Radix Astragali 10-15 parts, Radix Angelicae Dahuricae 10-15 parts, 20 parts of Fructus Xanthii.A kind of manufacture method of the medicine for treating nasal cavity inflammation,
The manufacture method is comprised the following steps:A, by Radix Glycyrrhizae, Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder,
Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Squama Maniss, sandwort, Herba Asari, Radix Sophorae Flavescentiss, Fructus Gleditsia, the Radix Astragali, the Radix Angelicae Dahuricae, Fructus Xanthii immersion boiling water middling speed scald one
Quickly pick up after lower, the raw material after then speed is scalded is dried;B, by the raw material after drying respectively with steel mill smash, then carried out
Sieve;C, Radix Glycyrrhizae, Fructus Gleditsia, the Radix Astragali are put in pot and are stir-fried, till parching to brown, be subsequently poured into standby in vessel;Fall in d, past pot
Enter cotton oil, slow fire is boiled;E, by Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi,
Squama Maniss, sandwort, Herba Asari, Radix Sophorae Flavescentiss, the Radix Angelicae Dahuricae and Fructus Xanthii are poured in the pot for be equipped with cotton oil and are boiled, and boil 30 minutes;f、
Radix Glycyrrhizae after step c, Fructus Gleditsia, the Radix Astragali are added in pot, is stirred;Proper amount of gypsum is added to be carried in g, past pot
Firmly;H, by carry it is hard after raw material dry;I, the raw material for drying is put in microwave oven and is toasted, then with steel mill by raw material powder
It is broken, obtain final product medicine of the present invention;J, by obtained medicine in step i be put in plastic casing seal.The cotton oil weight poured in step d
With Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Squama Maniss, sandwort, Herba Asari,
The ratio of the weight summation of Radix Sophorae Flavescentiss, the Radix Angelicae Dahuricae and Fructus Xanthii is 1:1.
Embodiment:By Radix Glycyrrhizae 3-5 parts, Flos Lonicerae 3-5 parts, Medulla Tetrapanacis 3-5 parts, Herba Menthae 3-5 parts, Rhizoma Chuanxiong 3-5 parts, Flos Magnoliae 5-10
Part, Semen Cassiae 5-10 parts, Radix Notoginseng powder 5-10 parts, Radix Saposhnikoviae 5-10 parts, Herba Ephedrae 5-10 parts, Folium Artemisiae Argyi 5-10 parts, 5 parts of Squama Maniss, goose are not
Food 10-15 parts, Herba Asari 10-15 parts, Radix Sophorae Flavescentiss 10-15 parts, Fructus Gleditsia 10-15 parts, Radix Astragali 10-15 parts, Radix Angelicae Dahuricae 10-15 parts and Fructus Xanthii
20 parts are scalded with boiling water speed and pick up, and are then dried, to drying after Radix Glycyrrhizae, Fructus Gleditsia, the Radix Astragali stir-fry, in addition again by gold silver
Flower, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Squama Maniss, sandwort, Herba Asari, Radix Sophorae Flavescentiss,
The Radix Angelicae Dahuricae and Fructus Xanthii are poured in the pot for be equipped with cotton oil and are stir-fried, and after stir-frying, Radix Glycyrrhizae, Fructus Gleditsia, the Radix Astragali are added in pot and stirred
Uniformly, then toward in pot add a little Gypsum Fibrosum to carry out carrying hard, then raw material is dried, then insert baking in microwave oven, finally grind
Get up into powder packaging.When using, the direct enterprising patient's nasal cavity of the medicine of this powder can not entered blood circulation, not hindered
Liver and kidney.
The ultimate principle and principal character and advantages of the present invention of the present invention, the technology of the industry has been shown and described above
Personnel it should be appreciated that the present invention is not restricted to the described embodiments, the simply explanation described in above-described embodiment and description this
The principle of invention, without departing from the spirit and scope of the present invention, the present invention also has various changes and modifications, these changes
Change and improvement is both fallen within scope of the claimed invention, invention is claimed, and scope is by appending claims and its waits
Effect thing is defined.
Claims (3)
1. a kind of medicine for treating nasal cavity inflammation, it is characterised in that its raw material comprising following weight portion:Radix Glycyrrhizae 3-5 parts, gold silver
It is flower 3-5 parts, Medulla Tetrapanacis 3-5 parts, Herba Menthae 3-5 parts, Rhizoma Chuanxiong 3-5 parts, Flos Magnoliae 5-10 parts, Semen Cassiae 5-10 parts, Radix Notoginseng powder 5-10 parts, anti-
Wind 5-10 parts, Herba Ephedrae 5-10 parts, Folium Artemisiae Argyi 5-10 parts, 5 parts of Squama Maniss, sandwort 10-15 parts, Herba Asari 10-15 parts, Radix Sophorae Flavescentiss 10-15
Part, Fructus Gleditsia 10-15 parts, Radix Astragali 10-15 parts, Radix Angelicae Dahuricae 10-15 parts, 20 parts of Fructus Xanthii.
2. a kind of manufacture method of the medicine for treating nasal cavity inflammation, it is characterised in that the manufacture method is comprised the following steps:
A, by Radix Glycyrrhizae, Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Squama Maniss,
Sandwort, Herba Asari, Radix Sophorae Flavescentiss, Fructus Gleditsia, the Radix Astragali, the Radix Angelicae Dahuricae, Fructus Xanthii immersion boiling water middling speed are quickly picked up after scalding, then scald speed
Raw material afterwards is dried;
B, by the raw material after drying respectively with steel mill smash, then sieved;
C, Radix Glycyrrhizae, Fructus Gleditsia, the Radix Astragali are put in pot and are stir-fried, till parching to brown, be subsequently poured into standby in vessel;
D, pour toward in pot cotton oil into, slow fire is boiled;
E, by Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Squama Maniss, goose not
Food, Herba Asari, Radix Sophorae Flavescentiss, the Radix Angelicae Dahuricae and Fructus Xanthii are poured in the pot for be equipped with cotton oil and are boiled, and boil 30 minutes;
F, the Radix Glycyrrhizae by after step c, Fructus Gleditsia, the Radix Astragali are added in pot, are stirred;
Proper amount of gypsum is added in g, past pot to carry out carrying hard;
H, by carry it is hard after raw material dry;
I, the raw material for drying is put in microwave oven and is toasted, then ground raw material pulverizing with steel, obtain final product medicine of the present invention;
J, by obtained medicine in step i be put in plastic casing seal.
3. the manufacture method of a kind of medicine for treating nasal cavity inflammation according to claim 2, it is characterised in that in step d
The cotton oil weight poured into and Flos Lonicerae, Medulla Tetrapanacis, Herba Menthae, Rhizoma Chuanxiong, Flos Magnoliae, Semen Cassiae, Radix Notoginseng powder, Radix Saposhnikoviae, Herba Ephedrae, Folium Artemisiae Argyi, Chuan Shan
The ratio of the weight summation of first, sandwort, Herba Asari, Radix Sophorae Flavescentiss, the Radix Angelicae Dahuricae and Fructus Xanthii is 1:1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710068880.XA CN106619817A (en) | 2017-02-08 | 2017-02-08 | Medicine for treating inflammation of nasal cavity, and preparation method of medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710068880.XA CN106619817A (en) | 2017-02-08 | 2017-02-08 | Medicine for treating inflammation of nasal cavity, and preparation method of medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106619817A true CN106619817A (en) | 2017-05-10 |
Family
ID=58844593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710068880.XA Pending CN106619817A (en) | 2017-02-08 | 2017-02-08 | Medicine for treating inflammation of nasal cavity, and preparation method of medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106619817A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107823399A (en) * | 2017-12-15 | 2018-03-23 | 贵州健瑞安药业有限公司 | A kind of preparation method for being used to preventing or treating the external preparation of rhinitis, liniment and ointment |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101947257A (en) * | 2010-06-02 | 2011-01-19 | 许小丽 | Nano silver-selenium negative ion strongly-antibacterial aerosol for preventing and curing rhinitis and influenza |
| CN102973656A (en) * | 2012-12-31 | 2013-03-20 | 上海浦东高星生物技术研究所 | Medicament for treating chronic rhinitis |
| CN104352587A (en) * | 2014-10-20 | 2015-02-18 | 周羿 | Ointment for treating rhinitis |
-
2017
- 2017-02-08 CN CN201710068880.XA patent/CN106619817A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101947257A (en) * | 2010-06-02 | 2011-01-19 | 许小丽 | Nano silver-selenium negative ion strongly-antibacterial aerosol for preventing and curing rhinitis and influenza |
| CN102973656A (en) * | 2012-12-31 | 2013-03-20 | 上海浦东高星生物技术研究所 | Medicament for treating chronic rhinitis |
| CN104352587A (en) * | 2014-10-20 | 2015-02-18 | 周羿 | Ointment for treating rhinitis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107823399A (en) * | 2017-12-15 | 2018-03-23 | 贵州健瑞安药业有限公司 | A kind of preparation method for being used to preventing or treating the external preparation of rhinitis, liniment and ointment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178809B (en) | A kind of skin external application medicine for clearing heat, detoxifying, reducing swelling, promoting blood circulation, relieving pain and promoting granulation and its processing method into medicament | |
| CN101658551A (en) | Honeysuckle composition for resisting virus diseases of pigs | |
| CN106619817A (en) | Medicine for treating inflammation of nasal cavity, and preparation method of medicine | |
| CN104027619A (en) | Traditional Chinese medicine for treating oral ulcer | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN102716224B (en) | Decoction formula for curing rhinitis and preparation method thereof | |
| CN107137688A (en) | A kind of ointment for treating nasosinusitis | |
| CN101716296A (en) | Traditional Chinese medicine pill for treating psoriasis | |
| CN105816616A (en) | Traditional Chinese medicine for postpartum lactogenesis | |
| CN104000966A (en) | Medicament for treating pharyngitis | |
| CN104758862A (en) | Kunbao plaster | |
| CN105770165A (en) | Compound traditional Chinese medicine oral liquid used for treating puerperal uterine inflammations | |
| CN108926638A (en) | A kind of rhinitis Chinese materia medica preparation and production method | |
| CN103479981B (en) | Plaster for treating sore and furuncle and innominate toxic swelling | |
| CN102861204A (en) | Medicine for preventing and treating postpartum diseases of ruminants and preparation method thereof | |
| CN108014222A (en) | Treat medicinal liquor of rheumatism and preparation method thereof | |
| CN106310095A (en) | Medicine for oral use for treating gynaecopathia | |
| CN107970423A (en) | A kind of preparation of resolving sputum restoring consciouness medicine | |
| CN100381149C (en) | Chinese medicinal capsule for treating breast phymatosis | |
| CN104707053A (en) | Traditional Chinese medicine composition for curing cervicitis | |
| CN103566327A (en) | Asthma-relieving decoction and preparation method thereof | |
| CN105148049A (en) | Traditional Chinese medicine decoction for treating irregular menstruation | |
| CN106075260A (en) | A kind of slender acanthopanax bark spirit | |
| CN105596917A (en) | Chinese herbal medicine ointment both used for external application and oral administration, and preparation method thereof | |
| CN105581214A (en) | Mixed ingredients of natural green plum powder and making method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |